Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 9/2014

01.09.2014 | Head and Neck

Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma

verfasst von: Thomas F. Pezier, Iain J. Nixon, Anil Joshi, Teresa Guerrero-Urbano, Richard Oakley, Jean-Pierre Jeannon, Ricard Simo

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

The increasing use of primary chemoradiation (CRT) for laryngeal squamous cell carcinoma (SCC) means that historical surgical data sets are not representative of the modern laryngectomy patient. We analyse a contemporary total laryngectomy (TL) cohort to identify factors predictive of outcome. This is a retrospective consecutive case note review in a UK tertiary referral centre. Demographic, staging, treatment and outcome data were collected. Oncological outcomes are expressed using the Kaplan–Meier method. The log-rank test was used for univariate analysis and cox regression for multivariate analysis. Sixty consecutive patients between 2003 and 2010 underwent primary TL, 28 including partial pharyngectomy. Median age was 61 years and mean follow-up was 24 months (1–78 months). Thirty six patients died during the study period, 24 of their disease. Of the disease-specific deaths, two occurred peri-operatively, four from local, two from regional and 18 from distant disease [two patients had simultaneous local and distant recurrence (DR)]. Five-year overall survival, disease-specific survival, loco-regional recurrence-free survival and distant recurrence-free survival (DRFS) were 36, 51, 87, 62 %, respectively. Of 17 parameters analysed, pN-stage, extra-capsular spread, a non-cohesive tumour front, thyroid infiltration and involvement of level 6 were significant predictors of disease-specific survival (DSS) on univariate analysis. pN > 1 and the presence of adverse histological features were found to be independent predictors of DSS and DRFS on multivariate analysis. Neither was significantly associated with loco-regional recurrence-free survival. Around half of patients who undergo TL for stage IV SCC will die of disease within 5 years, with most deaths attributable to DR. Surgery provides excellent loco-regional control but patients, especially those with advanced nodal disease and/or adverse histological features, should be thoroughly screened for occult distant disease.
Level of evidence 4.
Literatur
2.
Zurück zum Zitat Shah JP, Karnell LH, Hoffman HT, Ariyan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH, Fremgen A (1997) Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg 123(5):475–483PubMedCrossRef Shah JP, Karnell LH, Hoffman HT, Ariyan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH, Fremgen A (1997) Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg 123(5):475–483PubMedCrossRef
5.
7.
Zurück zum Zitat Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991). N Engl J Med 324(24):1685–1690. doi:10.1056/NEJM199106133242402 Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991). N Engl J Med 324(24):1685–1690. doi:10.​1056/​NEJM199106133242​402
8.
Zurück zum Zitat Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098. doi:10.1056/NEJMoa031317 PubMedCrossRef Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098. doi:10.​1056/​NEJMoa031317 PubMedCrossRef
9.
Zurück zum Zitat Ferlito A, Shaha AR, Lefebvre JL, Silver CE, Rinaldo A (2002) Organ and voice preservation in advanced laryngeal cancer. Acta Otolaryngol 122(4):438–442PubMedCrossRef Ferlito A, Shaha AR, Lefebvre JL, Silver CE, Rinaldo A (2002) Organ and voice preservation in advanced laryngeal cancer. Acta Otolaryngol 122(4):438–442PubMedCrossRef
11.
Zurück zum Zitat Ganly I, Patel SG, Matsuo J, Singh B, Kraus DH, Boyle J, Wong RJ, Lee N, Pfister DG, Shaha AR, Shah JP (2009) Predictors of outcome for advanced-stage supraglottic laryngeal cancer. Head Neck 31(11):1489–1495. doi:10.1002/hed.21113 PubMedCrossRef Ganly I, Patel SG, Matsuo J, Singh B, Kraus DH, Boyle J, Wong RJ, Lee N, Pfister DG, Shaha AR, Shah JP (2009) Predictors of outcome for advanced-stage supraglottic laryngeal cancer. Head Neck 31(11):1489–1495. doi:10.​1002/​hed.​21113 PubMedCrossRef
12.
Zurück zum Zitat Franchin G, Minatel E, Gobitti C, Talamini R, Vaccher E, Sartor G, Politi D, Trovo MG, Barzan L (2003) Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer 98(4):765–772. doi:10.1002/cncr.11575 PubMedCrossRef Franchin G, Minatel E, Gobitti C, Talamini R, Vaccher E, Sartor G, Politi D, Trovo MG, Barzan L (2003) Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer 98(4):765–772. doi:10.​1002/​cncr.​11575 PubMedCrossRef
13.
Zurück zum Zitat Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA (2001) Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 111(6):1079–1087. doi:10.1097/00005537-200106000-00028 PubMedCrossRef Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA (2001) Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 111(6):1079–1087. doi:10.​1097/​00005537-200106000-00028 PubMedCrossRef
14.
Zurück zum Zitat Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G, Lefebvre JL (2003) Cancer of the larynx. Crit Rev Oncol Hematol 47(1):65–80PubMedCrossRef Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G, Lefebvre JL (2003) Cancer of the larynx. Crit Rev Oncol Hematol 47(1):65–80PubMedCrossRef
15.
Zurück zum Zitat Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Robbins KT (2002) Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 24(5):456–467. doi:10.1002/hed.10069 PubMedCrossRef Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Robbins KT (2002) Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 24(5):456–467. doi:10.​1002/​hed.​10069 PubMedCrossRef
16.
Zurück zum Zitat Matsuo JM, Patel SG, Singh B, Wong RJ, Boyle JO, Kraus DH, Shaha AR, Zelefsky MJ, Pfister DG, Shah JP (2003) Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Annals Surg 238(3):412–421. doi:10.1097/01.sla.0000086660.35809.8a; (discussion 421–412) Matsuo JM, Patel SG, Singh B, Wong RJ, Boyle JO, Kraus DH, Shaha AR, Zelefsky MJ, Pfister DG, Shah JP (2003) Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Annals Surg 238(3):412–421. doi:10.​1097/​01.​sla.​0000086660.​35809.​8a; (discussion 421–412)
17.
Zurück zum Zitat de Juan J, Garcia J, Lopez M, Orus C, Esteller E, Quer M, Leon X (2013) Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma. JAMA Otolaryngol Head Neck Surg 139(5):483–488. doi:10.1001/jamaoto.2013.2666 PubMedCrossRef de Juan J, Garcia J, Lopez M, Orus C, Esteller E, Quer M, Leon X (2013) Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma. JAMA Otolaryngol Head Neck Surg 139(5):483–488. doi:10.​1001/​jamaoto.​2013.​2666 PubMedCrossRef
Metadaten
Titel
Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma
verfasst von
Thomas F. Pezier
Iain J. Nixon
Anil Joshi
Teresa Guerrero-Urbano
Richard Oakley
Jean-Pierre Jeannon
Ricard Simo
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 9/2014
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-013-2779-3

Weitere Artikel der Ausgabe 9/2014

European Archives of Oto-Rhino-Laryngology 9/2014 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Bilateraler Hörsturz hat eine schlechte Prognose

15.04.2024 Hörsturz Nachrichten

Die Mehrzahl der Menschen mit Hörsturz ist einseitig betroffen, doch auch ein beidseitiger Hörsturz ist möglich. Wie häufig solche Fälle sind und wie sich ihr Verlauf darstellt, hat eine HNO-Expertenrunde aus den USA untersucht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.